SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare’s arm recalls 19,812 bottles of Paroxetine tablets from US market

08 Dec 2017 Evaluate

Cadila Healthcare’s arm - Zydus Pharmaceuticals USA Inc, is recalling 19,812 bottles of Paroxetine tablets in the strength of 30 mg from the US market.  The reason for the voluntary nationwide recall is presence of foreign tablets/capsules: Risperidone tablets were found in bottle of Paroxetine tablets. The product was manufactured by Cadila Healthcare.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.



Zydus Lifesciences Share Price

938.70 -3.85 (-0.41%)
20-Apr-2026 14:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.75
Dr. Reddys Lab 1233.95
Cipla 1231.60
Zydus Lifesciences 938.70
Lupin 2328.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×